Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorGokdemir, Ebru
dc.contributor.authorOncu, Seyma
dc.contributor.authorGelal, Ayse
dc.contributor.authorUcku, Reyhan
dc.contributor.authorArici, Mualla Aylin
dc.date.accessioned2025-12-28T16:40:40Z
dc.date.available2025-12-28T16:40:40Z
dc.date.issued2022
dc.identifier.issn2458-8938
dc.identifier.issn2564-7288
dc.identifier.urihttps://doi.org/10.30621/jbachs.948898
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1275114
dc.identifier.urihttps://hdl.handle.net/20.500.12933/2671
dc.description.abstractPurpose: To evaluate the knowledge, opinions and prescribing attitudes of physicians working in an university hospital about biosimilar drugs and analyse the factors affect these parameters. Methods: In this descriptive, cross-sectional study, data was collected using a questionnaire consisting of 5 sections and 41 questions evaluating the knowledge, opinions and prescribing attitudes of physicians about biosimilar drugs. Descriptive statistics was used to report the findings; relationship between dependent and independent variables were examined using the t-test for parametric data, and Mann Whitney U and Kruskall Wallis analysis for nonparametric data. P <0.05 was considered statistically significant. Results: Questionnaire response rate was 61.9% (n=114). Physicians mean knowledge score about biosimilar drugs was 7.6 +/- 2.5 out of 14 points. Have heard the concept the biosimilar drug, had training towards biosimilar drugs and high academic level were increased the mean knowledge score. Of the respondents, 45.2% of the physicians stated that biosimilar drugs are not as effective as biological reference drugs, and 35.9% thought that they aren't safe. More than half of the physicians (56.6%) stated that they did not hesitate to prescribe biosimilar drugs. Conclusions: Physicians' general knowledge level on biosimilar drugs was low and they had doubts about the efficacy and safety of biosimilar drugs. This might be related with lack of knowledge. Therefore structured training programmes related in this area, might increase the knowledge level and might positively affect physicians' opinions and attitudes on biosimilar drugs
dc.language.isoen
dc.publisherDokuz Eylul Univ Inst Health Sciences
dc.relation.ispartofJournal of Basic And Clinical Health Sciences
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBiosimilar drug
dc.subjectlevel of knowledge
dc.subjectopinion
dc.subjectattitude
dc.subjectpyhsicians
dc.titleTHE KNOWLEDGE, OPINIONS, ATTITUDES OF PHYSICIANS ABOUT BIOSIMILAR DRUGS: A UNIVERSITY HOSPITAL DATA
dc.typeArticle
dc.identifier.orcid0000-0003-2468-2416
dc.identifier.orcid0000-0003-0254-571X
dc.identifier.orcid0000-0003-1910-7847
dc.departmentAfyonkarahisar Sağlık Bilimleri Üniversitesi
dc.identifier.doi10.30621/jbachs.948898
dc.identifier.volume6
dc.identifier.issue2
dc.identifier.startpage316
dc.identifier.endpage324
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.department-temp[Gokdemir, Ebru] Dokuz Eylul Univ, Inst Hlth Sci, MsC Clin Res, Izmir, Turkey; [Oncu, Seyma] Afyonkarahisar Univ Hlth Sci, Dept Med Pharmacol, Afyon, Turkey; [Gelal, Ayse; Arici, Mualla Aylin] Dokuz Eylul Univ, Sch Med, Dept Med Pharmacol, Div Clin Pharmacol, Izmir, Turkey; [Ucku, Reyhan] Dokuz Eylul Univ, Sch Med, Dept Publ Hlth, Izmir, Turkey
dc.identifier.trdizinid1275114
dc.identifier.wosWOS:000809667400035
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.snmzKA_WoS_20251227


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster